Successful Outcomes with Oral Fluoroquinolones Combined with Rifampicin in the Treatment of Mycobacterium ulcerans: An Observational Cohort Study

BACKGROUND: The World Health Organization currently recommends combined streptomycin and rifampicin antibiotic treatment as first-line therapy for Mycobacterium ulcerans infections. Alternatives are needed when these are not tolerated or accepted by patients, contraindicated, or neither accessible n...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Brien, Daniel P., McDonald, Anthony, Callan, Peter, Robson, Mike, Friedman, N. Deborah, Hughes, Andrew, Holten, Ian, Walton, Aaron, Athan, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260310/
https://www.ncbi.nlm.nih.gov/pubmed/22272368
http://dx.doi.org/10.1371/journal.pntd.0001473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260310/
https://www.ncbi.nlm.nih.gov/pubmed/22272368
http://dx.doi.org/10.1371/journal.pntd.0001473

Ejemplares similares